Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Editorial

Legislating prevention

CMAJ January 31, 2006 174 (3) 289; DOI: https://doi.org/10.1503/cmaj.060006
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Epidemiology, which began mainly as a tool to investigate the causes of infectious diseases, has in recent decades been used to study chronic noninfectious conditions. The result has been a growing appreciation of risk factors for these diseases, many of which are potentially modifiable. To date, however, government response to this new information has been limited to health promotion — healthy eating guides, for example. Should governments go further and use their legislative muscle to bring about changes in risk factor exposures of the population?

The World Health Organization (WHO) projected that, in 2005, 35 million people worldwide would die from heart disease, stroke, cancer and other chronic diseases. Chronic diseases would account for 72% of the global burden of disease in adults 30 years of age or older.1 A large proportion of these deaths would occur in people between the ages of 30 to 69 and could be delayed by preventive measures, not only reducing suffering but attenuating the economic burden of disease that disproportionately affects developing countries.1

The WHO's research into the global burden of disease also shows that a high proportion of the world's illness can be attributed to a relatively small number (20 or so) of modifiable risk factors; most illness, however, is multifactorial and is influenced by societal and environmental contexts. Even seemingly disparate factors can interact with one another, aggravating risk and making the task of prevention more complex. For example, in developed countries as much as 69% of the burden of chronic obstructive pulmonary disease (COPD) might be attributable to tobacco use; in developing countries that burden may be attributed not only to tobacco use (26%) but also to indoor air pollution from solid fuels (26%).2

In affluent countries that enjoy economic and environmental conditions favourable to health, we speak a good deal about “lifestyle” factors in disease risk, implying that our ailments — obesity, hypertension, cardiovascular disease, diabetes, cancer — are to some significant degree the fruits of our own unhealthy choices. The prevention “message,” directed mainly at individuals, is delivered by health care professionals, but as any family physician or public health department knows, lifestyle modification is fine in theory but disappointing in practice.

We should all take as much responsibility as we are able for our own health. However, the “lifestyle” label of certain risk factors should not restrict prevention to the level of the individual. It is also within the capacity of governments to implement policies that create preconditions for health and attenuate risk factors for disease. For example, to limit individual (and population) exposure to the risks inherent in high-calorie foods laden with trans-fats, governments can move the levers of agricultural, industrial and taxation policy to discourage production, limit distribution and regulate marketing of unhealthy foods. Already there are some examples, such as the federal requirement in Canada for detailed food labelling and, in the UK, a proposed Children's Food Bill that, if enacted, will enable controls to be placed on the marketing of non-nutritious foods to children and the sale of these products in schools. Those who resent the “nannyism” of such measures might reflect that regulations that now seem entirely commonsensical — such as the use of seat belts in cars — drew similar complaints when they were first proposed.3

At the same time, we should remember that the epidemiologic data supporting the influence of lifestyle factors on illness and health derive from follow-up (cohort) studies, not randomized clinical trials. Such data are notoriously susceptible to confounding effects; we know that people who are likely to live longer eat less, exercise more and are unlikely to smoke tobacco, but their longevity may be attributable to factors quite unrelated to these facts. In addition, the relative risks or odds ratios associated with modifiable factors are typically small (in the range of 15% to 20% [odds ratio 1.15 to 1.20]), making them susceptible to bias and confounding. The difficulty of gauging the rewards of lifestyle modification for any particular person may explain at least part of the reluctance of individuals to confront their risk factors. At a population level, however, even modest reductions in relative risk can result in large reductions in premature death and increases in national productivity. There is a role for more aggressive involvement of governments at all levels to formally address these “lifestyle” risk factors through policy and legislation. These actions should be considered by all government departments, not just ministries of health. — CMAJ

REFERENCES

  1. 1.↵
    Strong K, Mathers C, Leeder S, et al. Preventing chronic diseases: How many lives can we save? Lancet 2005;366:1578-82.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Ezzati M, Vander Hoorn S, Rodgers A, et al. Potential health gains from reducing multiple risk factors. In: Ezzati M, Lopez AD, Rodgers A, et al, editors. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004. p. 2167-90.
  3. 3.↵
    Cottam R. Is public health coercive health? Lancet 2005;366:1592-4.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 174 (3)
CMAJ
Vol. 174, Issue 3
31 Jan 2006
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Legislating prevention
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Legislating prevention
CMAJ Jan 2006, 174 (3) 289; DOI: 10.1503/cmaj.060006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Legislating prevention
CMAJ Jan 2006, 174 (3) 289; DOI: 10.1503/cmaj.060006
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Regard sur la santé des personnes noires et le racisme anti-Noirs dans les systèmes de santé au Canada
  • A focus on access to health care in Canada
  • L’avenir de la médecine est ici et vous en êtes la trame narrative
Show more Éditorial

Similar Articles

Collections

  • Topics
    • Exercise & physical activity
    • Public health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire